1. Novel tetrahydroquinoline derivatives induce ROS-mediated apoptosis in glioblastoma cells
   Shabnaz Koochakkhani et al, 2024, European Journal of Pharmaceutical Sciences CrossRef
2. MicroRNA‑30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin�1 and inhibiting autophagy
   Jing Xu et al, 2018, Experimental and Therapeutic Medicine CrossRef
3. HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas
   JING HE et al, 2015, International Journal of Oncology CrossRef
4. A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
   Zhifang Hu et al, 2020, Frontiers in Oncology CrossRef
5. Cell death in glioblastoma and the central nervous system
   Kyle Malone et al, 2024, Cellular Oncology CrossRef
6. Inhibition of Human Glioma Cell Proliferation Caused by Knockdown of Utrophin Using a Lentivirus-Mediated System
   Shang-Hang Shen et al, 2016, Cancer Biotherapy and Radiopharmaceuticals CrossRef
7. Difference in the Inhibitory Effect of Temozolomide on TJ905 Glioma Cells and Stem Cells
   Feng Jin et al, 2017, Frontiers in Neurology CrossRef
8. Inhibitors of apoptosis: clinical implications in cancer
   Mervat S. Mohamed et al, 2017, Apoptosis CrossRef
9. GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells
   Shiyi Wang et al, 2019, Experimental and Therapeutic Medicine CrossRef
10. Inhibitory effect of gefitinib derivative LPY‑9 on human glioma
    Yuchen Sun et al, 2021, Molecular Medicine Reports CrossRef